Structure-based Design on Anticancer Drug Discovery

Curr Top Med Chem. 2020;20(10):813-814. doi: 10.2174/156802662010200331100200.

Author

Haizhen Andrew Zhong¹

Affiliation

¹ Department of Chemistry University of Nebraska at Omaha 6001 Dodge Street Omaha, NE 68182, United States.

PMID: 32463006
DOI: 10.2174/156802662010200331100200

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antibodies, Monoclonal / chemistry
Antibodies, Monoclonal / pharmacology
Antineoplastic Agents / chemistry*
Antineoplastic Agents / pharmacology*
Biomarkers, Tumor / metabolism
Computer Simulation
Drug Discovery
Enzyme Inhibitors / chemistry
Enzyme Inhibitors / pharmacology
Humans
Molecular Targeted Therapy
Neoplasms / drug therapy*
Structure-Activity Relationship

Substances

Antibodies, Monoclonal
Antineoplastic Agents
Biomarkers, Tumor
Enzyme Inhibitors